COMP <GO>
HNGE vs SPCX // OPERATING MARGIN
Hinge Health Inc. (NYSE) VS. Space Exploration Technologies Corp. (NASDAQ) • 15-METRIC TALLY: HNGE 2
— SPCX 8
▲ OPERATING MARGIN LEADER: SPCX
LAST: $115.48 (+1.01%) • MKT CAP: $9.32B
operating-margins
-60.00%
LAST: $136.37 (+1.23%) • MKT CAP: $1.85T
operating-margins
21.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HNGE VS. SPCX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HNGE | SPCX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 79.60% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 58.30% | -93.30 | SPCX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 14.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.81% | 3.99% | -2.18 | SPCX | /fcf-yield <GO> |
| Operating Margin ACTIVE | -60.00% | 21.10% | -81.10 | SPCX | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 16.40% | -76.40 | SPCX | /net-margins <GO> |
| Revenue Growth (YoY) | 50.60% | 20.90% | +29.70 | HNGE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 12.12 | 26.00 | -13.88 | SPCX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.3 | 41.1 | +24.20 | HNGE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.24 | 1.36 | -0.12 | SPCX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.0x | 18.2x | +10.80 | SPCX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.32B | $1.85T | -$1.84T | SPCX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HNGE REV | SPCX REV | HNGE GROSS % | SPCX GROSS % | HNGE FCF | SPCX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $587.9M | $38.67B | 79.6% | — | $170.7M | $0 |
| FY 2024 | $390.4M | — | 76.8% | — | $48.0M | — |
| FY 2023 | $292.7M | — | — | — | -$77.1M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HNGE // BETA 1.24
SPCX // BETA 1.36